It seems we can’t find what you’re looking for. Perhaps searching can help.
Now approved for use in Pediatrics
Treatment of pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA).
Treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.
Please click here for the full Prescribing information, including Boxed Warning regarding embryo-fetal toxicity, hypersensitivity reactions, and severe adverse reactions.
